204 related articles for article (PubMed ID: 1791793)
21. Intravenous immunoglobulin: new clinical applications.
Steele RW; Burks AW; Williams LW
Ann Allergy; 1988 Feb; 60(2):89-94. PubMed ID: 2829663
[TBL] [Abstract][Full Text] [Related]
22. Prenatal and postnatal prophylaxis of infections in preterm neonates.
von Muralt G; Sidiropoulos D
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S72-8. PubMed ID: 3135529
[TBL] [Abstract][Full Text] [Related]
23. [Value of intravenous immunoglobulins for the prophylaxis and treatment of neonatal infections].
Magny JF
Arch Fr Pediatr; 1992; 49(6):547-50. PubMed ID: 1449358
[No Abstract] [Full Text] [Related]
24. Safety of intravenous immunoglobulin (IVIG) therapy.
Katz U; Achiron A; Sherer Y; Shoenfeld Y
Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
[TBL] [Abstract][Full Text] [Related]
25. [The indications for intravenous immunoglobulins in pediatric practice].
Popescu V; Bleahu D
Pediatrie (Bucur); 1992; 41(1):37-45. PubMed ID: 1322724
[TBL] [Abstract][Full Text] [Related]
26. [Prevention of infections in primary and secondary antibody deficiency].
Mikołuć B; Pietrucha B; Motkowski R; Wolska-Kuśnierz B; Heropolitańska-Pliszka E; Bernatowska E
Przegl Epidemiol; 2009; 63(1):55-60. PubMed ID: 19522227
[TBL] [Abstract][Full Text] [Related]
27. [New indications for gamma globulins].
Fontán G; García MC; Pascual-Salcedo D; López Trascasa M; Alvarez Doforno R; Ferreira A
An Esp Pediatr; 1992 Jun; 36 Suppl 48():135-8. PubMed ID: 1379010
[TBL] [Abstract][Full Text] [Related]
28. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
Rütter A; Luger TA
Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
[TBL] [Abstract][Full Text] [Related]
29. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
Hurez V; Kaveri SV; Kazatchkine MD
J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
[TBL] [Abstract][Full Text] [Related]
30. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
Sapir T; Blank M; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
[TBL] [Abstract][Full Text] [Related]
31. Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
Gold R; Stangel M; Dalakas MC
Nat Clin Pract Neurol; 2007 Jan; 3(1):36-44. PubMed ID: 17205073
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg?
Lamoureux J; Aubin E; Lemieux R
Int Immunol; 2004 Jul; 16(7):929-36. PubMed ID: 15159376
[TBL] [Abstract][Full Text] [Related]
33. Subcutaneous administration of IgG.
Berger M
Immunol Allergy Clin North Am; 2008 Nov; 28(4):779-802, viii. PubMed ID: 18940574
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
[TBL] [Abstract][Full Text] [Related]
35. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
Emmi L; Chiarini F
Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
[TBL] [Abstract][Full Text] [Related]
36. [The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies].
Lewandowicz-Uszyńska A; Jankowski A
Pol Merkur Lekarski; 2011 Jun; 30(180):409-12. PubMed ID: 21751549
[TBL] [Abstract][Full Text] [Related]
37. [Intravenous IgG for treatment of neuromuscular diseases].
Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
[TBL] [Abstract][Full Text] [Related]
38. Established and new uses of intravenous immunoglobulin.
Cunningham-Rundles C
Mt Sinai J Med; 1992 Sep; 59(4):335-40. PubMed ID: 1406751
[TBL] [Abstract][Full Text] [Related]
39. Human intravenous immunoglobulin in primary and secondary antibody deficiencies.
Stiehm ER
Pediatr Infect Dis J; 1997 Jul; 16(7):696-707. PubMed ID: 9239774
[TBL] [Abstract][Full Text] [Related]
40. Should therapeutic immunoglobulin be considered a generic product? An evidence-based approach.
Misbah SA
J Allergy Clin Immunol Pract; 2013; 1(6):567-72. PubMed ID: 24565702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
